Metastatic or Refractory Soft Tissue Sarcomas and Metronomic Cyclophosphamide: Further Assessment of Efficacy and Safety
CompletedOBSERVATIONAL
Enrollment
60
Participants
Timeline
Start Date
January 1, 2005
Primary Completion Date
December 31, 2021
Study Completion Date
July 1, 2022
Conditions
SarcomaSoft Tissue Sarcoma
All Listed Sponsors
lead
Centre Hospitalier Universitaire de Besancon
OTHER
NCT06216990 - Metastatic or Refractory Soft Tissue Sarcomas and Metronomic Cyclophosphamide: Further Assessment of Efficacy and Safety | Biotech Hunter | Biotech Hunter